기관회원 [로그인]
소속기관에서 받은 아이디, 비밀번호를 입력해 주세요.
개인회원 [로그인]

비회원 구매시 입력하신 핸드폰번호를 입력해 주세요.
본인 인증 후 구매내역을 확인하실 수 있습니다.

회원가입
서지반출
Whole-Body Bone Scan Findings after High-Intensity Focused Ultrasound (HIFU) Treatment
[STEP1]서지반출 형식 선택
파일형식
@
서지도구
SNS
기타
[STEP2]서지반출 정보 선택
  • 제목
  • URL
돌아가기
확인
취소
  • Whole-Body Bone Scan Findings after High-Intensity Focused Ultrasound (HIFU) Treatment
  • Whole-Body Bone Scan Findings after High-Intensity Focused Ultrasound (HIFU) Treatment
저자명
Seo. Ye-Young,O. Joo-Hyun,Sohn. Hyung-Sun,Choi. Eun-Kyoung,Yoo. Ik-Dong,Oh. Jin-Kyoung,Han. Eun-Ji,Jung. Seung-Eun,Kim. Sung-Hoo
간행물명
Nuclear medicine and molecular imaging : NMMI
권/호정보
2011년|45권 4호|pp.268-275 (8 pages)
발행정보
대한핵의학회
파일정보
정기간행물|ENG|
PDF텍스트
주제분야
기타
이 논문은 한국과학기술정보연구원과 논문 연계를 통해 무료로 제공되는 원문입니다.
서지반출

기타언어초록

Purpose This study aims to examine the findings of $^{99m}Tc$-diphosphonate bone scans in cancer patients with a history of HIFU treatment. Methods Bone scan images of patients with a history of HIFU treatment for primary or metastatic cancer from January 2006 to July 2010 were retrospectively reviewed. Cases of primary bone tumor or HIFU treatment reaching only the superficial soft tissue layer were excluded. Results Bone scan images of 62 patients (26 female, 36 male; mean age $57{pm}9$ years) were studied. HIFU treatment was performed in the liver (n=40), pancreas (n=16), and breast (n=6). Mean interval time between HIFU treatment and bone scan was $106{pm}105$ days (range: 1-572 days). Of 62 scans, 43 showed diffusely decreased uptake of bone within the path of HIFU treatment: antero-axillary and/or posterior arcs of right 5th to 11th ribs in 34 cases after treatment of hepatic lesions; anterior arcs of 2nd to 5th ribs in 5 cases after treatment for breast tumors; and posterior arcs of left 9th to 11th ribs or thoracolumbar vertebrae in 4 cases after treatment for pancreas tumor. Of 20 patients who had bone scans more than twice, five showed recovered uptake of the radiotracer in the involved ribs in the follow-up bone scan. Conclusion Of 62 bone scans in patients with a history of HIFU treatment for primary or metastatic cancer, 69% presented diffusely decreased uptake in the bone in the path of HIFU treatment.